## STZ: Constellation Brands, Inc. - XLP: Consumer Defensive

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 4.3% in lower entry zone (4.0-10.0%), top quartile (81st pct) cross-sectional ranking. Short-term MRS_5 (1.7%) confirms momentum alignment. Strong momentum (+1.6% 5-day acceleration). Outperforming sector by 6.3%. Caution: overbought RSI (70).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($137.39)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Shareholders That Lost Money on Constellation Brands, Inc.(STZ) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More**
- Source: MyHighPlains.com | 20251207T150927 | Neutral | Relevance: 97%
-  Levi & Korsinsky, LLP is urging shareholders of Constellation Brands, Inc. (NYSE:STZ) who suffered losses between April 11, 2024, and January 8, 2025, to join a class action lawsuit. The lawsuit alleges securities fraud, citing a significant miss in the company's Beer segment sales and an even steeper miss in Wine & Spirits, which led to a dramatic decline in stock price. Shareholders are encouraged to contact the firm to learn about potential recovery.

**2. THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION**
- Source: Simply Wall Street | 20251207T043326 | Somewhat-Bullish | Relevance: 65%
-  MGP Ingredients (MGPI) has seen its stock price decline by 73% in two years, primarily due to an inventory correction in the brown goods (bulk distilled spirits) market, which the market has mistakenly priced as a structural decline. Despite this, MGPI maintains a strong balance sheet, positive operating cash flow, and possesses three accelerating growth engines: Penelope Bourbon, El Mayor Tequila, and its Ingredient Solutions segment. The article argues that MGPI is undervalued and positioned for a significant recovery through P/B revaluation, EBITDA multiple expansion, and potential consolidation opportunities as competitors face financial distress.

**3. Tilray (TLRY) Is Down 9.6% After Reverse Split And Beverage Pivot - What's Changed**
- Source: Simply Wall Street | 20251207T230906 | Neutral | Relevance: 64%
- Tilray Brands (TLRY) recently completed a 1-for-10 reverse stock split to maintain Nasdaq compliance and is significantly expanding its beverage and hemp-derived THC product lines. While the split aims to improve administrative efficiency and facilitate future capital raises, the company's long-term success hinges on its ability to diversify beyond core cannabis and achieve profitability amidst ongoing losses and regulatory uncertainties. Investors are closely watching whether non-cannabis segments can improve margins and offset pressures from the Canadian cannabis market.

**4. Gabelli Funds LLC Trims Stock Holdings in Diageo plc $DEO**
- Source: MarketBeat | 20251207T113203 | Neutral | Relevance: 63%
-  Gabelli Funds LLC significantly reduced its stake in Diageo plc by 4.1% in Q2, selling 22,500 shares and retaining 520,850 shares valued at approximately $52.52 million. This move reflects a broader weakening in analyst sentiment, with the company currently holding a consensus "Reduce" rating and a target price of $119. Diageo's shares have been trading near their 12-month low, below key moving averages, and institutional investors hold about 8.97% of the stock.

**5. MGP Ingredients, Inc.'s (NASDAQ:MGPI) Price Is Right But Growth Is Lacking**
- Source: Simply Wall Street | 20251207T043326 | Neutral | Relevance: 62%
-  MGP Ingredients, Inc. currently has a low price-to-sales (P/S) ratio of 0.9x, suggesting it might be undervalued compared to the broader Beverage industry. However, this low P/S ratio is attributed to MGP Ingredients' declining revenue, which has fallen by 22% in the last year and 24% over the past three years. Analysts forecast further revenue decline of 10% over the next year, contrasting with the industry's expected 5.0% growth, making the low P/S ratio understandable.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Piper Sandler | $135 | $155 | -13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Piper Sandler | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.5% (+3.2%)
- Berkshire Hathaway, : 7.7% (0.0%)
- Blackrock Inc.: 6.1% (-2.0%)
- Capital World Invest: 3.8% (-43.3%)
- State Street Corpora: 3.8% (-4.2%)

### Key Risks

1. Long-term trend broken: trading 11.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +1.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.58 elevated, pricing in significant growth expectations. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $25.0B |
| Beta | 0.46 |
| 52W Range | $126.45 - $245.31 |
| Short Interest | 5.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.58 |
| Forward P/E | 11.5 |
| Current P/E | 12.5 |
| YoY Growth | 8.0% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 2.6% to 4.3% (+1.6% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 81st percentile. MRS_5 at 1.7% confirms short-term momentum alignment. AM_20 at 6.5% shows strong absolute momentum above own 20MA. Outperforming sector by 6.3pp, stock-specific strength. Below SMA200 (0.88x), long-term trend not supportive. MACD histogram positive (1.39), confirming momentum. RSI overbought at 70, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.30% (CS: 82) | Strong |
| RSI_14 | 70.3 | Overbought |
| MACD Histogram | 1.39 | Bullish |
| vs SMA20 | 1.066x | Above |
| vs SMA50 | 1.055x | Above |
| vs SMA200 | 0.883x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $143.37
- **Stop Loss:** $137.39 (4.2% risk)
- **Target:** $152.34 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 83
- **Position Value:** $11,899.71
- **Portfolio %:** 11.90%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-07 (Est: $2.65)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.41 | $3.63 | +6.5% |
| 2025Q2 | $3.29 | $3.22 | -2.3% |
| 2025Q1 | $2.27 | $2.63 | +15.9% |
| 2024Q4 | $3.31 | $3.25 | -1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*